sales@angenesci.com
Login | Register
logo
Structures Search
Home Aminos 8-[(1R)-1-[(3,5-difluorophenyl)amino]ethyl]-N,N-dimethyl-2-(4-morpholinyl)-4-oxo-4H-1-benzopyran-6-carboxamide

8-[(1R)-1-[(3,5-difluorophenyl)amino]ethyl]-N,N-dimethyl-2-(4-morpholinyl)-4-oxo-4H-1-benzopyran-6-carboxamide

CAS No.:
1627494-13-6
Catalog Number:
AG001TE3
Molecular Formula:
C24H25F2N3O4
Molecular Weight:
457.4698
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1mg
≥98%
1 week
United States
$91
- +
5mg
99%
1 week
United States
$154
- +
10mg
99%
1 week
United States
$223
- +
25mg
≥98%
1 week
United States
$447
- +
50mg
99%
1 week
United States
$598
- +
100mg
99%
1 week
United States
$960
- +
Product Description
Catalog Number:
AG001TE3
Chemical Name:
8-[(1R)-1-[(3,5-difluorophenyl)amino]ethyl]-N,N-dimethyl-2-(4-morpholinyl)-4-oxo-4H-1-benzopyran-6-carboxamide
CAS Number:
1627494-13-6
Molecular Formula:
C24H25F2N3O4
Molecular Weight:
457.4698
MDL Number:
MFCD27987908
IUPAC Name:
8-[(1R)-1-(3,5-difluoroanilino)ethyl]-N,N-dimethyl-2-morpholin-4-yl-4-oxochromene-6-carboxamide
InChI:
InChI=1S/C24H25F2N3O4/c1-14(27-18-11-16(25)10-17(26)12-18)19-8-15(24(31)28(2)3)9-20-21(30)13-22(33-23(19)20)29-4-6-32-7-5-29/h8-14,27H,4-7H2,1-3H3/t14-/m1/s1
InChI Key:
LMJFJIDLEAWOQJ-CQSZACIVSA-N
SMILES:
Fc1cc(cc(c1)F)N[C@@H](c1cc(cc2c1oc(cc2=O)N1CCOCC1)C(=O)N(C)C)C
UNII:
AIQ4OWD0RA
Properties
Complexity:
748  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0
Exact Mass:
457.181g/mol
Formal Charge:
0
Heavy Atom Count:
33  
Hydrogen Bond Acceptor Count:
8  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
457.478g/mol
Monoisotopic Mass:
457.181g/mol
Rotatable Bond Count:
5  
Topological Polar Surface Area:
71.1A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
3  
Literature
Title Journal
Inhibition of PI3Kβ signaling with AZD8186 inhibits growth of PTEN-deficient breast and prostate tumors alone and in combination with docetaxel. Molecular cancer therapeutics 20150101
Properties